Screening of Lactose Intolerance Among IBS Patients Diarrhea Dominant
NCT ID: NCT06931379
Last Updated: 2026-01-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
70 participants
OBSERVATIONAL
2026-01-31
2027-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Role of Irritable Bowel Syndrome in Lactose Intolerance (LION)
NCT05100719
Assessment of Colonic Permeability by Confocal Laser Endomicroscopy
NCT00883077
Predictive Value of Hydrogen/Methane Lactose Breath Testing on the Therapeutic Effect of Lactose-free Diet in Moderate to Severe ROME IV IBS.
NCT04974593
Clinical Utility of Breath Tests in GI
NCT03261856
Confocal Laser Endomicroscopy in IBS Patients
NCT02313207
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To determine the point prevalence of lactose intolerance in patients suffering from chronic diarrhea (lasting more than four weeks).
To explore potential correlations between lactose intolerance and demographic factors such as age and gender.
To identify the most common symptoms associated with lactose intolerance in this patient population.
Methodology:
Data Collection: Demographic information (age, sex, medical history, and diarrhea duration) will be gathered.
Lactose Intolerance Testing: Polymerase Chain Reaction (PCR) will be employed to diagnose lactose intolerance.
Symptom Questionnaire: A standardized questionnaire will be administered to document symptoms like abdominal pain, bloating, flatulence, diarrhea, and nausea.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
adult patients aged 18-70 years diagnosed as IBS diarrhea dominant
The target population comprises individuals who meet the following inclusion criteria:
Adults aged between 18 and 70 years.
Diagnosed with IBS diarrhea dominant
Both males and females are eligible for participation.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Related to defecation (pain improves or worsens with bowel movements).
2. Change in stool frequency (diarrhea or constipation).
3. Change in stool form (appearance) (loose, watery, hard, or lumpy).
* Patients aged \>18 years.
* Both males and females
Exclusion Criteria
* Patients with chronic diarrhea don't meet Rome criteria
* patients with malignancies
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Christina Shahat Ayoub
resident at the tropical medicine department
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Screening of lactose intolera
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.